You are here

  • Home
  • Archive
  • Volume 12, Issue Suppl 1
  • APCU 29 Exploring the effects of sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) in elderly patients with heart failure with reduced ejection fraction (HFrEF), with and without type 2 diabetes mellitus (T2DM)

Article info

Article menu

Download PDFPDF

APCU 29 Exploring the effects of sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) in elderly patients with heart failure with reduced ejection fraction (HFrEF), with and without type 2 diabetes mellitus (T2DM)
Free

Authors

Citation

Hazwani I, Raja Abdul Wafy R, Abdul Muizz A
APCU 29 Exploring the effects of sodium-glucose cotransporter 2 inhibitor (SGLT2 inhibitor) in elderly patients with heart failure with reduced ejection fraction (HFrEF), with and without type 2 diabetes mellitus (T2DM)
Open Heart 2025;12:doi: 10.1136/openhrt-2024-APCU.29

Publication history

  • First published January 20, 2025.
Online issue publication 
January 20, 2025

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ.